Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. read more
John Crowley Amicus Therapeutics CEO Rating
John Crowley Amicus Therapeutics CEO Rating
Amicus Therapeutics' CEO, John Crowley, has 3 employee ratings and a score of 67/100, placing them in the Bottom 40% of similar size companies on Comparably with 51-200 Employees and Bottom 45% of other companies in New York.
Where This Score Ranks Amicus Therapeutics' CEO Rating
- BOTTOM40%
In the Bottom 40% of 2035 Similar Sized Companies on Comparably
- BOTTOM45%
In the Bottom 45% of 707 Nearby Companies in New York
- 1st
1st place versus 1 competitors rated on Comparably
100
Apr
95
Nov
C67 / 100
Jan
Amicus Therapeutics CEO John Crowley Bio
John Crowley serves as the CEO / President of Amicus Therapeutics.
Not Enough Ratings To Show Who Ranks CEO Rating the Highest
Anonymously rate my experience at Amicus TherapeuticsNot Enough Ratings To Show Who Ranks CEO Rating the Lowest
Anonymously rate my experience at Amicus TherapeuticsAmicus Therapeutics CEO John Crowley At a Glance
The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Amicus Therapeutics.
Overall, the CEO score has remained stable over the last 90 days.
Amicus Therapeutics CEO John Crowley Rating Trendline
- Amicus Therapeutics67
- Other Companies in New York
- Similar Size on Comparably
Amicus Therapeutics' CEO Rating Rank Against Similar Sized Companies on Comparably
BOTTOM
40%
Amicus Therapeutics ranks in the Bottom 40% of other companies on Comparably with 51-200 Employees for CEO Rating Score.
Amicus Therapeutics' CEO Rating Rank Against Other Companies Nearby
BOTTOM
45%
Amicus Therapeutics ranks in the Bottom 45% of other companies in New York for CEO Rating Score.
Anonymously Ask Amicus Therapeutics Any Question
Questions Recently Asked asked Amicus Therapeutics
Are You an Employee at Amicus Therapeutics?
Anonymously Rate Your Experience & Make Work BetterSee other culture dimensions at Amicus Therapeutics
×